THEXYA
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Apr 2022)
What this means for you
This application is over — abandoned 18 Apr 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88620012
- Mark type
- Stylized text
- Filed
- 17 Sept 2019
- Published for opposition
- 21 Jan 2020
- Abandoned
- 18 Apr 2022
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome
Owner
- Shire Human Genetic Therapies, Inc., Lexington, MA, US
- Shire Human Genetic Therapies, Inc., Lexington, MA, US
Prosecution history
- 18 Apr 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Apr 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jul 2021 — SOU EXTENSION 3 GRANTED
- 06 Jul 2021 — SOU EXTENSION 3 FILED
- 06 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2021 — SOU EXTENSION 2 GRANTED
- 04 Mar 2021 — SOU EXTENSION 2 FILED
- 04 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2020 — SOU EXTENSION 1 GRANTED
- 28 Jul 2020 — SOU EXTENSION 1 FILED
- 28 Jul 2020 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED